Global Research Antibodies Market Size By Technology, By End User, By Product, By Application, By Geographic Scope And Forecast
연구용 항체 시장 규모 및 예측
연구용 항체 시장 규모는 2021년에 108억 7,000만 달러로 평가되며, 2023년부터 2030년까지 연평균 6.75% 성장하여 2030년에는 195억 5,000만 달러에 달할 것으로 예상됩니다. 정부는 단백질체학 및 유전체학 연구에 막대한 자금을 지원하고 있으며, 이는 세계 연구용 항체 시장의 급격한 성장으로 이어지고 있습니다. 세계 연구용 항체 시장 보고서는 시장의 전반적인 평가를 제공합니다. 주요 부문, 동향, 시장 촉진요인, 경쟁 상황, 시장에서 중요한 역할을 하는 요인 등을 포괄적으로 분석합니다.
연구용 항체 세계 시장 정의
B세포로 구성된 단백질을 항체라고 합니다. 이 B세포는 우리 몸의 면역체계의 일부입니다. 항체의 주요 기능은 항원에 달라붙어 파괴의 신호를 보내는 것입니다. 이는 감염과 싸우는 데 도움이 됩니다. 연구용 항체는 특정 분자에 결합할 수 있어 세포 연구에 이상적인 프로브가 될 수 있습니다. 연구용 항체는 세포 내 단백질 기능을 연구하는 데 중요한 도구입니다.
연구용 항체 세계 시장 개요
연구용 항체 세계 시장 성장은 연구 활동의 증가에 의해 주도되고 있습니다. 기업들은 연구개발 활동에 많은 투자를 하고 있습니다. 산학협력의 활성화도 연구용 항체 세계 시장의 급격한 성장으로 이어지고 있습니다. 인도, 중국 등 신흥시장은 시장 성장의 새로운 기회를 창출할 것으로 보입니다. 그러나 위의 촉진요인과는 반대로 시장 성장을 억제하는 요인도 있습니다. 품질 및 결과의 재현성 부족에 대한 우려는 시장 성장에 부정적인 영향을 미칠 것으로 보입니다.
목차
제1장 세계의 연구용 항체 시장 소개
제2장 주요 요약
제3장 VERIFIED MARKET RESEARCH 조사 방법
- 데이터 마이닝
- 밸리데이션
- 1차 자료
- 데이터 소스 리스트
제4장 세계의 연구용 항체 시장 전망
- 개요
- 시장 역학
- Porter's Five Forces 모델
- 밸류체인 분석
- 규제 프레임워크
제5장 연구용 항체 세계 시장 : 기술별
- 웨스턴 블롯팅
- 유세포 분석
- 효소결합면역흡착측정법(ELISA)
- 면역조직화학
- 면역형광법
- 면역침강
- 기타 기술
제6장 연구용 항체 세계 시장 : 최종사용자별
- 제약·바이오테크놀러지 기업
- 학술·연구기관
- 수탁연구기관
제7장 연구용 항체 세계 시장 : 제품별
- 시약
- 배지·혈청
- 염색·색소
- 고정화제
- 완충액
- 용매
- 효소
- 프로브
- 기타 시약
- 항체
제8장 연구용 항체 세계 시장 : 용도별
제9장 연구용 항체 세계 시장 : 지역별
제10장 세계의 연구용 항체 시장 경쟁 구도
- 개요
- 각사의 시장 점유율
- 벤더 상황
- 주요 개발 전략
제11장 기업 개요
- Thermo Fisher Scientific Inc.
- Merck Group
- Abcam PLC
- Becton, Dickinson and Company
- Cell Signaling Technology, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Agilent Technologies, Inc.
- Danaher Corporation
- Lonza
- Genscript
- Perkinelmer, Inc.
- Biolegend, Inc.
제12장 주요 발전
- 제품 출시/개발
- 인수합병
- 사업 확대
- 파트너십과 제휴
제13장 부록
ksm
Research Antibodies Market Size And Forecast
Research Antibodies Market size was valued at USD 10.87 Billion in 2021 and is projected to reach USD 19.55 Billion by 2030, growing at a CAGR of 6.75% from 2023 to 2030. The governments are providing huge funds to proteomics and genomics research and that has led to the global Research Antibodies Market growing at a rapid pace. The Global Research Antibodies Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Research Antibodies Market Definition
The proteins which are made up of B cells are called antibodies. These B cells are part of the body's immune system. The primary function of the antibodies is to latch on to antigens and flag them for destruction. This helps in fighting infection. The research antibodies can bind specific molecules which makes them ideal probes in cell research. Research antibodies are an important tool when it comes to studying protein functions in cells.
Global Research Antibodies Market Overview
The growth of the Global Research Antibodies Market is being driven by increasing research activities. The companies are investing heavily in research and development activities. The growing industry-academia collaboration has also led to the rapid growth of the Global Research Antibodies Market. Emerging markets such as India and China will create new opportunities for the market to grow. However, contrary to the above drivers some restraints will limit the growth of the market. The concerns related to quality and lack of reproducible results will negatively influence the growth of the market.
Global Research Antibodies Market: Segmentation Analysis
The Global Research Antibodies Market is Segmented on the basis of Technology, End User, Product, Application, And Geography.
Research Antibodies Market, By Technology
- Western Blotting
- Flow Cytometry
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunohistochemistry
- Immunofluorescence
- Immunoprecipitation
- Other Technologies
Based on Technology, the market is bifurcated into Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and Other Technologies. The flow cytometry segment is dominating the market owing to its ability to perform simultaneous multi-parameter analysis on a single cell within a heterogeneous mixture.
Research Antibodies Market, By End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
Based on End User, the market is bifurcated into Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organizations. The pharmaceutical and biotechnology companies contributed majorly to the growth of the market as research antibodies are widely being used for drug development.
Research Antibodies Market, By Product
Based on Product, the market is bifurcated into Reagents and Antibodies. The reagents segment is further bifurcated into Media & Sera, Stains & Dyes, Fixatives, Buffers, Solvents, Enzymes, Probes, and Other Reagents. The antibodies segment is further bifurcated into By Type, By Source, and By Research Area.
Research Antibodies Market, By Application
- Proteomics
- Drug Development
- Genomics
Based on Application, the market is bifurcated into Proteomics, Drug Development, and Genomics. The proteomics segment dominated the market as it was able to effectively minimize the cost, time, and resource requirement for chemical synthesis and biological testing of drugs.
Research Antibodies Market, By Geography
- North America
- Europe
- Asia Pacific
- Rest of the world
- On the basis of Regional Analysis, the Global Research Antibodies Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share of the market will be dominated by North America. The dominance of the North American region is credited to the increasing investment in the development of structure-based drug designs.
Key Players
- The "Global Research Antibodies Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
- Thermo Fisher Scientific Inc., Merck Group, Abcam PLC, Becton, Dickinson and Company, Cell Signaling Technology, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Danaher Corporation, Lonza, Genscript, Perkinelmer, Inc., Biolegend, Inc.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Key Developments
- Partnerships, Collaborations and Agreements
- In 2018, Thermo Fisher Scientific Inc., collaborated with Montreal Neurological Institute with an aim to develop improved and new methods to both characterize and produce antibodies for advanced neurological research associated with Amyotrophic lateral sclerosis, Parkinson's disease, and other brain diseases.
- In 2020, Thermo Fisher Scientific (US) collaborated with Wuxi and Mayo Clinic To secure FDA authorization for testing COVID-19 with ELISA for detecting both IgM and IgG antibodies.
- Mergers and Acquisitions
- On September 2018, Roche announced the acquisition of Tusk Therapeutic Ltd. Tusk is a developer of an antibody that has a novel mode of action aimed at depleting regulatory T cells.
- In 2019, Thermo Fisher Scientific (US) acquired Brammer Bio (US) to expand its capacity for manufacturing viral vectors for gene and cell therapies with Brammer Bio's CDMO facilities. The acquisition was valued at USD 1.7 billion.
- Product Launches and Product Expansions
- On October 2021, Thermo Fisher Scientific, the world leader in serving science, has launched a new CE-IVD-marked COVID-19 test. The TaqPath COVID-19 Fast PCR Combo Kit 2.0. expands Thermo Fisher's menu of highly accurate tests that detect active SARS-CoV-2 infections.
TABLE OF CONTENTS
1 INTRODUCTION OF GLOBAL RESEARCH ANTIBODIES MARKET
- 1.1 Overview of the Market
- 1.2 Scope of Report
- 1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
- 3.1 Data Mining
- 3.2 Validation
- 3.3 Primary Interviews
- 3.4 List of Data Sources
4 GLOBAL RESEARCH ANTIBODIES MARKET OUTLOOK
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 4.5 Regulatory Framework
5 GLOBAL RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY
- 5.1 Western Blotting
- 5.2 Flow Cytometry
- 5.3 Enzyme-Linked Immunosorbent Assay (ELISA)
- 5.4 Immunohistochemistry
- 5.5 Immunofluorescence
- 5.6 Immunoprecipitation
- 5.7 Other Technologies
6 GLOBAL RESEARCH ANTIBODIES MARKET, BY END USER
- 6.1 Pharmaceutical and Biotechnology Companies
- 6.2 Academic and Research Institutes
- 6.3 Contract Research Organizations
7 GLOBAL RESEARCH ANTIBODIES MARKET, BY PRODUCT
- 7.1 Reagents
- 7.1.1 Media & Sera
- 7.1.2 Stains & Dyes
- 7.1.3 Fixatives
- 7.1.4 Buffers
- 7.1.5 Solvents
- 7.1.6 Enzymes
- 7.1.7 Probes
- 7.1.8 Other Reagents
- 7.2 Antibodies
- 7.2.1 By Type
- 7.2.1.1 Primary Antibodies
- 7.2.1.2 Secondary Antibodies
- 7.2.2 By Source
- 7.2.2.1 Mice
- 7.2.2.2 Rabbits
- 7.2.2.3 Other Sources
- 7.2.3 By Research Area
- 7.2.3.1 Oncology
- 7.2.3.2 Infectious Diseases
- 7.2.3.3 Immunology
- 7.2.3.4 Neurobiology
- 7.2.3.5 Stem Cells
- 7.2.3.6 Other Research Areas
8 GLOBAL RESEARCH ANTIBODIES MARKET, BY APPLICATION
- 8.1 Proteomics
- 8.2 Drug Development
- 8.3 Genomics
9 GLOBAL RESEARCH ANTIBODIES MARKET, BY GEOGRAPHY
- 9.1 Overview
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 U.K.
- 9.3.3 France
- 9.3.4 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Rest of Asia Pacific
- 9.5 Rest of the World
- 9.5.1 Latin America
- 9.5.2 Middle East and Africa
10 GLOBAL RESEARCH ANTIBODIES MARKET COMPETITIVE LANDSCAPE
- 10.1 Overview
- 10.2 Company Market Share
- 10.3 Vendor Landscape
- 10.4 Key Development Strategies
11 COMPANY PROFILES
- 11.1 Thermo Fisher Scientific Inc.
- 11.1.1 Overview
- 11.1.2 Financial Performance
- 11.1.3 Product Outlook
- 11.1.4 Key Developments
- 11.2 Merck Group
- 11.2.1 Overview
- 11.2.2 Financial Performance
- 11.2.3 Product Outlook
- 11.2.4 Key Developments
- 11.3 Abcam PLC
- 11.3.1 Overview
- 11.3.2 Financial Performance
- 11.3.3 Product Outlook
- 11.3.4 Key Developments
- 11.4 Becton, Dickinson and Company
- 11.4.1 Overview
- 11.4.2 Financial Performance
- 11.4.3 Product Outlook
- 11.4.4 Key Developments
- 11.5 Cell Signaling Technology, Inc.
- 11.5.1 Overview
- 11.5.2 Financial Performance
- 11.5.3 Product Outlook
- 11.5.4 Key Developments
- 11.6 Bio-Rad Laboratories, Inc.
- 11.6.1 Overview
- 11.6.2 Financial Performance
- 11.6.3 Product Outlook
- 11.6.4 Key Developments
- 11.7 F. Hoffmann-La Roche Ltd
- 11.7.1 Overview
- 11.7.2 Financial Performance
- 11.7.3 Product Outlook
- 11.7.4 Key Developments
- 11.8 Agilent Technologies, Inc.
- 11.8.1 Overview
- 11.8.2 Financial Performance
- 11.8.3 Product Outlook
- 11.8.4 Key Developments
- 11.9 Danaher Corporation
- 11.9.1 Overview
- 11.9.2 Financial Performance
- 11.9.3 Product Outlook
- 11.9.4 Key Developments
- 11.10 Lonza
- 11.10.1 Overview
- 11.10.2 Financial Performance
- 11.10.3 Product Outlook
- 11.10.4 Key Developments
- 11.11 Genscript
- 11.11.1 Overview
- 11.11.2 Financial Performance
- 11.11.3 Product Outlook
- 11.11.4 Key Developments
- 11.12 Perkinelmer, Inc.
- 11.12.1 Overview
- 11.12.2 Financial Performance
- 11.12.3 Product Outlook
- 11.12.4 Key Developments
- 11.13 Biolegend, Inc.
- 11.13.1 Overview
- 11.13.2 Financial Performance
- 11.13.3 Product Outlook
- 11.13.4 Key Developments
12 KEY DEVELOPMENTS
- 12.1 Product Launches/Developments
- 12.2 Mergers and Acquisitions
- 12.3 Business Expansions
- 12.4 Partnerships and Collaborations
13 Appendix
